Enrico Cortesi

Pubblicazioni

Titolo Pubblicato in Anno
Isochemotopic response: the first case on a scar GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA 2018
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: results from the Italian cohort of an expanded access program TUMOR BIOLOGY 2018
30 Gy single dose stereotactic body radiation therapy (SBRT). Report on outcome in a large series of patients with lung oligometastatic disease LUNG CANCER 2018
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program CLINICAL GENITOURINARY CANCER 2018
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program FUTURE ONCOLOGY 2018
Cancer immunotherapy in patients with brain metastases CANCER IMMUNOLOGY, IMMUNOTHERAPY 2018
Sequencing Radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: preliminary results from a retrospective study in Italian Centers JOURNAL OF CLINICAL ONCOLOGY 2018
Follow-up program in head and neck cancer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2017
Burned-out testicular cancer: really a different history? CASE REPORTS IN ONCOLOGY 2017
Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites HEAD & NECK 2017
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2017
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? ONCOIMMUNOLOGY 2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients JOURNAL OF CLINICAL ONCOLOGY 2017
Prolactin as a potential early predictive factor in metastatic non-small cell lung cancer patients treated with Nivolumab ONCOLOGY 2017
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence ANNALS OF ONCOLOGY 2017
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy JOURNAL OF CLINICAL ONCOLOGY 2016
Prostate-specific antigen flare phenomenon during 223Ra-Dichloride treatment for bone metastatic castration-resistant prostate cancer: a case report CLINICAL GENITOURINARY CANCER 2016
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab SCIENTIFIC REPORTS 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience THE BREAST 2016
P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety ANNALS OF ONCOLOGY 2016

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma